The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Have You Heard

Tuesday, 11 April 2017
The latest review of diabetes foot care in England and Wales shows significant room for improvement. The National Diabetes Foot Care Audit (NDFA) 2014-2016 found that less than half of diabetes services in England and Wales have the recommended NICE care structures in place. In addition, 40% of ulcer episodes referred by a health professional only had an expert assessment after 2 or more weeks.
Category: Have You Heard
Topics covered:
Sunday, 12 March 2017
Recently announced results from the FOURIER trial show that treatment with the PCSK9 inhibitor evolocumab significantly reduced the risk of cardiovascular events in patients with clinical atherosclerotic cardiovascular disease on optimized statin therapy.
Category: Have You Heard
Sunday, 12 March 2017
For the first time the European Commission has approved the use of a diabetes treatment for its effect on both blood sugar and cardiovascular events. Empagliflozin product information now includes data on the reduction of risk of cardiovascular death in addition to data on the improvement of blood sugar control.
Category: Have You Heard
Topics covered:
Sunday, 12 March 2017
A new fixed dose combination of saxagliptin (Onglyza) and dapagliflozin (Forxiga) is now available for use in adults with type 2 diabetes.
Category: Have You Heard
Topics covered:
Sunday, 12 March 2017
A useful free infographic provides international data on cardiovascular drug adherence. Although the UK lags behind other European countries, it has better adherence rates than the USA, Australia and a number of South American countries.
Category: Have You Heard
Thursday, 02 February 2017
A practical down-to-earth manual on the whole range of long-term conditions has been written for UK general practice nurses by experts in their field. The book provides a quick way for new practice nurses to learn the basics about long-term conditions and will also be useful to the wider primary healthcare team.
Category: Have You Heard
Wednesday, 04 January 2017
A new report from the Royal College of Physicians (RCP) highlights a wide range of improvements needed in the management of chronic obstructive pulmonary disease (COPD) care in primary care in England.
Category: Have You Heard
Topics covered:
Wednesday, 04 January 2017
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending extension of the label for all metformin-containing products to included patients with stable moderate renal failure (chronic kidney disease stage 3).
Category: Have You Heard
Topics covered:
Page 3 of 3

Article search and filter